COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?-Reference-Cited by-同舟云学术

COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?

Published:2022-12-07 Issue:1 Volume:14 Page:193-204
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Heald Adrian H.^ORCID,Jenkins David A.,Williams Richard,Mudaliar Rajshekhar N.,Naseem Asma,Davies Kelly A. Bowden,Gibson J. Martin,Peng Yonghong,Ollier William

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-022-01338-5.pdf

Reference23 articles.

1. https://www.who.int/health-topics/coronavirus: Accessed 24 July 2022

2. Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence? J Clin Hypertens (Greenwich). 2020;22:943–8.

3. Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Somasundaram NP, Matthews DR. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63:1440–52.

4. Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8:813–22.

5. Heald AH, Jenkins DA, Williams R, Sperrin M, Fachim H, Mudaliar RN, Syed A, Naseem A, Gibson JM, Bowden Davies KA, Peek N, Anderson SG, Peng Y, Ollier W. The Risk Factors potentially influencing hospital admission in people with diabetes, following SARS-CoV-2 infection: a population-level analysis. Diabetes Ther. 2022;13:1007–21.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy;Cardiovascular Endocrinology & Metabolism;2024-05-23

2. An Overview of Real-World Data Infrastructure for Cancer Research;Clinical Oncology;2024-03

3. Ranting in 2024: It's Not More of the Same;Diabetes Technology & Therapeutics;2024-02-01

4. Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England;Diabetes Therapy;2023-08-25

5. Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection—Induction of Autoimmune Dysregulation and Metabolic Disturbances;International Journal of Molecular Sciences;2023-07-18